Omeros (OMER) Invested Capital (2011 - 2025)
Omeros (OMER) reported Invested Capital of $1.2 million for Q4 2025, down 37.94% on a YoY basis from $2.0 million in Q4 2024, and down 95.45% sequentially from $26.9 million in Q1 2025.
Omeros (OMER) Invested Capital (2011 - 2025) Analysis & Trends
Omeros (OMER) has 12 years of Invested Capital data on file, last reported at $1.2 million in Q4 2025.
- For the quarter ending Q4 2025, Invested Capital fell 37.94% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 95.76% YoY), and the FY2025 full-year result was $1.2 million, down 37.94% from the prior year.
- Invested Capital declined to $1.2 million in Q4 2025, from $26.9 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $94.9 million in Q3 2023 to a low of $1.2 million in Q4 2025.
- A 4-year average of $51.2 million and a median of $60.7 million in 2022 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital tumbled 98.63% in 2023 and surged 53.14% in 2024, its largest moves.
- Tracing OMER's Invested Capital over 4 years: stood at $94.4 million in 2022, then plunged by 98.63% to $1.3 million in 2023, then surged by 53.14% to $2.0 million in 2024, then tumbled by 37.94% to $1.2 million in 2025.
- Business Quant data shows OMER's Invested Capital at $1.2 million in Q4 2025, $26.9 million in Q1 2025, and $2.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.23 Mn |
| Mar 31, 2025 | 26.93 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 94.91 Mn |
| Jun 30, 2023 | 94.73 Mn |
| Mar 31, 2023 | 94.55 Mn |
| Dec 31, 2022 | 94.38 Mn |
| Dec 31, 2019 | 2.77 Mn |
| Mar 31, 2019 | 2.56 Mn |
| Dec 31, 2018 | 889,000.00 |
| Sep 30, 2018 | 560,000.00 |
| Jun 30, 2018 | 608,000.00 |
| Mar 31, 2018 | 513,000.00 |
| Dec 31, 2017 | 490,000.00 |
| Sep 30, 2017 | 368,000.00 |
| Jun 30, 2017 | 250,000.00 |
| Mar 31, 2017 | 228,000.00 |
| Dec 31, 2016 | 198,000.00 |
| Sep 30, 2016 | 190,000.00 |